References
- Üçeyler N , VollertJ , BrollBet al. Sensory profiles and skin innervation of patients with painful and painless neuropathies. Pain159(9), 1867–1876 (2018).
- Devigili G , TugnoliV , PenzaPet al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain131(7), 1912–1925 (2008).
- Tavee J , ZhouL. Small fiber neuropathy: a burning problem. Cleve. Clin. J. Med.76(5), 297–305 (2009).
- Hovaguimian A , GibbonsCH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr. Pain Headache Rep.15(3), 193–200 (2011).
- Tseng M-T , PanC-L , HsiehS-T. Overview of small fiber neuropathy. In: Small Fiber Neuropathy and Related Syndromes: Pain and Neurodegeneration.AnandP, GibbonsCH, SommerC ( Eds). Springer Singapore, Singapore, 3–10 (2019).
- Terkelsen AJ , KarlssonP , LauriaG , FreemanR , FinnerupNB , JensenTS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol.16(11), 934–944 (2017).
- Sindrup SH , JensenTS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain83(3), 389–400 (1999).
- Shaygan M , BögerA , Kröner-HerwigB. Predicting factors of outcome in multidisciplinary treatment of chronic neuropathic pain. J. Pain Res.11, 2433–2443 (2018).
- Schütz SG , Robinson-PappJ. HIV-related neuropathy: current perspectives. HIV. AIDS (Auckl).5, 243–251 (2013).
- Jeon YH . Spinal cord stimulation in pain management: a review. Korean J. Pain25(3), 143–150 (2012).
- Melzack R , WallPD. Pain mechanisms: a new theory. Science150(3699), 971–978 (1965).
- Petersen EA , StaussTG , ScowcroftJAet al. Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy. JAMA Neurol.78(6), 687–698 (2021).
- Kamdar MM , McCallLW , SabaAM , WaingerBJ. Improvement in neuropathic pain, proprioception, and gait stability after spinal cord stimulator implantation for chemotherapy-induced peripheral neuropathy. Pain Med. Case Rep.5(6), 291–295 (2021).
- Senza Spinal Cord Stimulation System. U.S. Food and Drug Administration (2021). www.fda.gov/medical-devices/recently-approved-devices/senza-spinal-cord-stimulation-system-p130022s039
- Bakkers M , FaberCG , HoeijmakersJGJ , LauriaG , MerkiesISJ. Small fibers large impact: quality of life in small-fiber neuropathy. Muscle Nerve49(3), 329–336 (2014).
- Van Buyten J-P , Al-KaisyA , SmetI , PalmisaniS , SmithT. High-frequency spinal cord stimulation for the treatment of chronic back pain patients: results of a prospective Multicenter European Clinical Study. Neuromodulation Technol. Neural Interface16(1), 59–66 (2013).
- Youn Y , SmithH , MorrisB , ArgoffC , PilitsisJG. The effect of high-frequency stimulation on sensory thresholds in chronic pain patients. Stereotact. Funct. Neurosurg.93(5), 355–359 (2015).
- Shechter R , YangF , XuQet al. Conventional and kilohertz-frequency spinal cord stimulation produces intensity- and frequency-dependent inhibition of mechanical hypersensitivity in a rat model of neuropathic pain. Anesthesiology119(2), 422–432 (2013).
- Knezevic NN , CandidoKD , RanaS , KnezevicI. The use of spinal cord neuromodulation in the management of HIV-related polyneuropathy. Pain Physician18(4), E643–50 (2015)
- Cameron T . Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J. Neurosurg. Spine100(3), 254–267 (2004).